Role of CEACAM1, ECM, and Mesenchymal Stem Cells in an Orthotopic Model of Human Breast Cancer
Table 2
Effect of extracellular matrix on differentiation of xenografts.
MEC 1
SC2
ECM
Outcome
None
hTert MSC (2 105)
Matrigel orCol I plus matrigel (3 : 1)
8
—
No growth or no xenogratfs
MCF7 (2 105)
None
Col I plus matrigel (3 : 1)
8
0/16
Solid tumor
MCF7/CEACAM1-4S (2 105)
None
Col I plus matrigel (3 : 1)
8
0/16
Solid tumor and no differentiation
MCF7 (2 105)
hTert MSC (2 105)
None
8
0/4
Solid tumor and low engraftment
MCF7/CEACAM1-4S (2 105)
hTert MSC (2 105)
None
8
0/3
Solid tumor and low engraftment
MCF7 (2 105)
None
Matrigel
8
0/16
Solid tumor
MCF7/CEACAM1-4S (2 105)
None
Matrigel
8
15/16*
Differentiation into acini
1Mammary epithelial cellline (number of cells injected), 2Stromal cell line (number of cells injected), 3Number of animals, 4Number of xenografts exhibiting gland-like structures ()/Total number of xenografts (), *indicates statistical significance () for differentiation of xenografts, when compared with all other groups in this table.